Position
Fidelity in Viking Therapeutics, Inc.
Back to the book · All holders of VKTX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $39M$32.54 → $39.01
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 6.56M | $230.7M | — | — | — | 0.0% |
| Q1 2026 | 6.02M | $196M | $32.54 | −$15.9M | −$18.8M | 0.0% |
| Q2 2026 | 6.34M | $247.2M | $39.01 | $39M | $12.1M | 0.0% |